Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

Similar articles for PubMed (Select 20620929)

1.

Clinical application of gene expression profiling in breast cancer.

Sparano JA, Fazzari M, Kenny PA.

Surg Oncol Clin N Am. 2010 Jul;19(3):581-606. doi: 10.1016/j.soc.2010.03.008. Review.

PMID:
20620929
2.

Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.

Staaf J, Ringnér M, Vallon-Christersson J, Jönsson G, Bendahl PO, Holm K, Arason A, Gunnarsson H, Hegardt C, Agnarsson BA, Luts L, Grabau D, Fernö M, Malmström PO, Johannsson OT, Loman N, Barkardottir RB, Borg A.

J Clin Oncol. 2010 Apr 10;28(11):1813-20. doi: 10.1200/JCO.2009.22.8775. Epub 2010 Mar 15.

3.
4.

Prognostic applications of gene expression signatures in breast cancer.

Normanno N, De Luca A, Carotenuto P, Lamura L, Oliva I, D'Alessio A.

Oncology. 2009;77 Suppl 1:2-8. doi: 10.1159/000258489. Epub 2010 Feb 2. Review.

PMID:
20130425
5.

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.

Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL.

BMC Genomics. 2006 May 26;7:127.

6.

Tumor gene expression and prognosis in breast cancer patients with 10 or more positive lymph nodes.

Cobleigh MA, Tabesh B, Bitterman P, Baker J, Cronin M, Liu ML, Borchik R, Mosquera JM, Walker MG, Shak S.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8623-31.

7.

Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome.

Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

Ann Surg Oncol. 2007 Oct;14(10):2994-3003. Epub 2007 Jul 24.

PMID:
17647064
8.

Current status of prognostic profiling in breast cancer.

Pusztai L.

Oncologist. 2008 Apr;13(4):350-60. doi: 10.1634/theoncologist.2007-0216. Review.

9.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
10.

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

Brenton JD, Carey LA, Ahmed AA, Caldas C.

J Clin Oncol. 2005 Oct 10;23(29):7350-60. Epub 2005 Sep 6. Review.

PMID:
16145060
11.

Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.

Kreike B, van Kouwenhove M, Horlings H, Weigelt B, Peterse H, Bartelink H, van de Vijver MJ.

Breast Cancer Res. 2007;9(5):R65.

12.

Factors predictive of response to hormone therapy in breast cancer.

Rastelli F, Crispino S.

Tumori. 2008 May-Jun;94(3):370-83. Review.

13.

Population-based molecular prognosis of breast cancer by transcriptional profiling.

Ma Y, Qian Y, Wei L, Abraham J, Shi X, Castranova V, Harner EJ, Flynn DC, Guo L.

Clin Cancer Res. 2007 Apr 1;13(7):2014-22.

14.

Gene expression profiling of primary breast cancer.

Rouzier R, Wagner P, Morandi P, Pusztai L.

Curr Oncol Rep. 2005 Jan;7(1):38-44. Review.

PMID:
15610685
15.

Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice.

Diaz LK, Cryns VL, Symmans WF, Sneige N.

Adv Anat Pathol. 2007 Nov;14(6):419-30. Review.

PMID:
18049131
16.

Biomolecular features of clinical relevance in breast cancer.

Daidone MG, Paradiso A, Gion M, Harbeck N, Sweep F, Schmitt M.

Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S3-14. Epub 2004 Apr 17. Review.

PMID:
15095022
17.

Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?

Correa Geyer F, Reis-Filho JS.

Int J Surg Pathol. 2009 Aug;17(4):285-302. doi: 10.1177/1066896908328577. Epub 2008 Dec 22. Review.

PMID:
19103611
18.

Genomics-based prognosis and therapeutic prediction in breast cancer.

Jeffrey SS, Lønning PE, Hillner BE.

J Natl Compr Canc Netw. 2005 May;3(3):291-300. Review.

PMID:
16002001
19.

Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

Thorat MA, Marchio C, Morimiya A, Savage K, Nakshatri H, Reis-Filho JS, Badve S.

J Clin Pathol. 2008 Mar;61(3):327-32. Epub 2007 Nov 23.

PMID:
18037662
20.

CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer.

O'Brien SL, Fagan A, Fox EJ, Millikan RC, Culhane AC, Brennan DJ, McCann AH, Hegarty S, Moyna S, Duffy MJ, Higgins DG, Jirström K, Landberg G, Gallagher WM.

Int J Cancer. 2007 Apr 1;120(7):1434-43.

PMID:
17205517
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk